OutSense

OutSense

An advanced medical IoT platform capable of analyzing and diagnosing human waste from within a standard toilet bowl

Founded 2016 Israel

Israel 23 employees Series A Total: $2.87M Biotechnology, Health Care +1

OutSense is an innovative startup with the slogan "An advanced medical IoT platform capable of analyzing and diagnosing human waste from within a standard toilet bowl." Founded in 2015 and based in Israel, OutSense has developed a ground-breaking technology that allows for the accurate analysis and diagnosis of human waste directly from a standard toilet bowl. This pioneering solution offers a superior monitoring platform, contributing to the preservation of health and the early detection of various medical conditions. OutSense's unique technology has garnered significant attention, with the most recent milestone being a $500.00K Series A investment on 07 June 2021 by Longevity Venture Partners. The company operates within the Biotechnology and Health Care industries, leveraging its revolutionary database on human extracts to provide invaluable insights into human physiology. Overall, OutSense's innovative approach to medical diagnostics through its IoT platform holds strong potential for transforming the health care industry, making it a compelling investment opportunity for venture capitalists.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	$500.00K	1	Longevity Venture Partners	07 Jun 2021
Series A	$2.20M	1	Peregrine Ventures	09 Nov 2020
Grant	€50.00K	1	EASME - EU Executive Agency for SMEs	10 Jan 2017
Seed Round	$120.00K	1	Peregrine Ventures	01 Aug 2016

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

$500.00K

Longevity Venture Partners

07 Jun 2021

Series A

$2.20M

Peregrine Ventures

09 Nov 2020

Grant

€50.00K

EASME - EU Executive Agency for SMEs

10 Jan 2017

Seed Round

$120.00K

Peregrine Ventures

01 Aug 2016

FAQ About OutSense

An advanced medical IoT platform capable of analyzing and diagnosing human waste from within a standard toilet bowl

OutSense was founded in 2016.

OutSense is headquartered in Israel.

OutSense operates in Biotechnology, Health Care and Health and Wellness. Its work centres on biological analysis, health monitoring, early detection and colorectal cancer.

OutSense has approximately 23 employees.

OutSense has completed 4 funding rounds, raising a total of $2.87M. The latest funding stage is Series A.

Top alternatives and competitors to OutSense include JuneBrain Inc., 诺辉健康 New Horizon Health Limited, OncoDiag, Motus GI Medical Technologies, Kite Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

OutSense and JuneBrain Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About OutSense

Funding Rounds & Investors (4)

OutSense Alternatives & Competitors

FAQ About OutSense